GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Handok 002390.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

8,290

+0.12%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩535.14bn

FY2016FY2025

Net income

−₩2.15bn

FY2016FY2025

Free cash flow

−₩11.86bn

FY2016FY2025

Shareholders' equity

₩276.61bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩535.14bn₩507.36bn₩522.74bn₩543.76bn₩517.64bn₩503.61bn₩473.00bn₩446.73bn₩417.97bn₩396.13bn
Gross profit₩158.93bn₩157.41bn₩166.35bn₩173.71bn₩167.55bn₩168.39bn₩166.00bn₩157.77bn₩132.86bn₩127.51bn
Research and development₩21.19bn₩22.63bn₩28.67bn₩24.00bn₩22.88bn₩20.13bn₩19.24bn₩21.12bn₩22.45bn₩18.47bn
Operating income₩3.29bn₩538.5m₩12.58bn₩28.50bn₩28.01bn₩48.21bn₩33.56bn₩22.07bn₩12.20bn₩3.64bn
Net income−₩2.15bn−₩52.56bn−₩28.80bn₩10.68bn₩3.29bn₩26.96bn₩34.93bn₩7.99bn₩4.87bn−₩6.45bn
Diluted earnings per share-156.43-3,819.00-2,092.31776.22239.391,958.782,537.78586.71391.11-518.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩790.75bn₩788.55bn₩790.34bn₩871.11bn₩841.56bn₩818.93bn₩748.67bn₩652.62bn₩639.35bn₩622.85bn
Total liabilities₩512.43bn₩499.49bn₩449.71bn₩489.25bn₩457.57bn₩437.08bn₩404.67bn₩339.24bn₩348.63bn₩333.60bn
Debt₩80.51bn₩142.91bn₩123.78bn₩184.69bn₩138.79bn₩152.85bn₩213.65bn₩158.43bn₩188.95bn₩167.63bn
Shareholders' equity₩276.61bn₩287.26bn₩338.73bn₩379.81bn₩384.00bn₩381.30bn₩340.74bn₩307.38bn₩284.29bn₩280.87bn
Shares outstanding14m14m14m14m14m14m14m14m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩3.98bn−₩2.79bn₩35.98bn₩30.52bn₩37.23bn₩24.34bn₩8.80bn₩29.46bn₩6.79bn−₩8.50bn
Capital spending−₩15.84bn−₩19.40bn−₩26.18bn−₩36.20bn−₩43.02bn−₩20.44bn−₩22.03bn−₩15.77bn−₩29.15bn−₩31.69bn
Free cash flow−₩11.86bn−₩22.19bn₩9.80bn−₩5.69bn−₩5.79bn₩3.90bn−₩13.23bn₩13.69bn−₩22.36bn−₩40.19bn
Dividends paid−₩2.75bn−₩4.13bn−₩5.51bn−₩4.82bn−₩4.13bn−₩3.78bn−₩6.13bn−₩3.30bn−₩1.56bn−₩1.24bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩140.73bn₩135.43bn₩140.05bn₩144.68bn₩130.53bn₩119.87bn₩121.28bn₩129.04bn
Gross profit₩42.97bn₩39.52bn₩43.27bn₩39.89bn₩39.62bn₩36.14bn₩35.99bn₩36.32bn
Operating income₩2.77bn₩753.2m₩4.54bn₩7.79bn₩218.5m−₩3.82bn—−₩2.51bn
Net income−₩12.72bn−₩8.55bn₩7.94bn₩3.95bn−₩6.36bn−₩7.69bn−₩33.44bn−₩3.99bn
Diluted earnings per share-923.86-621.03577.05287.09-462.18-558.39-2,429.78-289.72
Cash from operations₩9.66bn₩154.0m−₩16.13bn₩11.37bn₩9.13bn−₩390.0m₩16.66bn−₩7.11bn
Capital spending−₩3.22bn−₩2.61bn−₩3.51bn−₩5.58bn−₩3.66bn−₩3.08bn−₩4.21bn−₩7.04bn
Free cash flow₩6.44bn−₩2.46bn−₩19.64bn₩5.78bn₩5.47bn−₩3.47bn₩12.45bn−₩14.15bn
Total assets₩779.69bn₩798.75bn₩790.75bn₩804.42bn₩774.61bn₩822.12bn₩788.55bn₩811.32bn
Debt₩118.62bn₩78.79bn₩80.51bn₩74.20bn₩82.70bn₩150.73bn₩142.91bn₩149.99bn
Shareholders' equity₩253.29bn₩266.23bn₩276.61bn₩266.17bn₩260.69bn₩277.98bn₩287.26bn₩318.56bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.5%1.2%4.1%
Operating income-51.3%-41.5%-6.2%
Net income——2.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin30.3%31.1%31.7%32.5%
Operating margin0.4%2.1%3.9%3.8%
Net margin-5.2%-3.5%-1.4%-0.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-71.6-3.2-6.821.695.217.08.952.384.4-50.6
Price to sales0.30.30.40.40.60.90.70.91.00.8

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 26 Feb 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year200.00200.00300.00400.00350.00300.00275.00450.00
  • 10-for-1 split · 2 May 2003
  • 1.096-for-1 split · 15 Dec 1994
  • 6-for-5 split · 3 Jan 1994
  • 21-for-20 split · 4 Apr 1990
  • 21-for-20 split · 6 Apr 1989

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.